Judy Lynn Chase is a pharmacist who is specialized in Oncology in Houston, Texas. Patients can reach her at 1515 Holcombe Blvd., Unit 90, Houston or contact her on 713-792-2870. Active license number of Judy Lynn Chase is 30435 for Oncology in Texas. Judy Lynn Chase is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Judy Lynn Chase speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Judy Lynn Chase
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Female
Location:
1515 Holcombe Blvd., Unit 90, Houston, Texas, 77030-4009
Phone:
713-792-2870
Fax:
713-563-2958
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Judy Lynn Chase are as mentioned below.
NPI Number:
1205057809
NPI Enumeration Date:
01 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Judy Lynn Chase are as mentioned below.
Specialization
License Number
State
Status
Oncology
30435
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1515 Holcombe Blvd., Unit 90 Houston, Texas
Zip:
77030-4009
Phone Number:
713-792-2870
Fax Number:
713-563-2958
Patients can reach Judy Lynn Chase at 1515 Holcombe Blvd., Unit 90, Houston, Texas or can call on phone at 713-792-2870.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.